- Mortality in patients with rheumatoid arthritis-associated interstitial lung disease treated with an anti-tumor necrosis factor agent
-
Koo BS, Hong S, Kim YJ, Kim YG, Lee CK, Yoo B
- KMID: 2129670
- Korean J Intern Med.
- 2015 Jan;30(1):104-109.
- doi: 10.3904/kjim.2015.30.1.104
BACKGROUND/AIMS: To evaluate the impact on mortality of anti-tumor necrosis factor (anti-TNF) treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD). METHODS: We retrospectively reviewed the medical records of 100 RA-ILD patients... -
- CITED
-
- Close
- SHARE
-
- Close
